Table 4 Outcomes of Patient with Pancreatic Adenocarcinoma
From: Arterial resection and reconstruction in pancreatectomy: surgical technique and outcomes
Operative Group | Chemotherapy Group | P value | |
|---|---|---|---|
Total Patients | 11 | 11 | |
Age, mean (yr) | 58 (30–78) | 61 (46–81) | 0.5004 |
Sex | 1.000 | ||
Male | 5 (45.6%) | 6 (54.4%) | |
Female | 6 (54.4%) | 5 (45.6%) | |
Tumor diameter, mean (cm) | 4 (3–6) | 4.1 (2.5–6) | 0.7399 |
TNM stage | III | III | |
Tumor location | 0.0841 | ||
Pancreatic head | 8 (72.7%) | 6 (54.4%) | |
Distal pancreas | 1 (9.1%) | 5 (45.6%) | |
Total pancreas | 2 (18.2%) | 0 (0%) | |
Chemotherapy protocols | 0.0292 | ||
GEM | 7 (63.6%) | 2 (18.2%) | |
GEMOX | 0 (0%) | 2 (18.2%) | |
GS | 1 (9.1%) | 5 (45.6%) | |
mFOLFIRINOX | 0 (0%) | 1 (9.1%) | |
AG | 0 (0%) | 1 (9.1%) | |
None | 3 (27.3%) | 0 (0%) | |
Median Survival (mo) | 11.7 (0.6–37.7) | 11.1 (0.7–36.9) | 0.922 |